The Zamora health management continues with the joint strategy of vaccination against COVID-19 and influenza aimed at the target population over 60 years of age and those people who belong to a risk group due to their vulnerability according to their disease (people with chronic diseases, with disabilities or cognitive deficits, with morbid obesity, etc.) as well as for their professional work in the province of Zamora.
For the administration of the booster and the anti-flu dose, as recalled by the Territorial Delegation of the Council, it is necessary to request an appointment through the Salud Castilla y León website, through the ‘Sacyl Conecta’ application, by phone call in the Administrative Units of the Health Centers or with the IVR system (Centro de Cita Previa de Tábara), or through the Healthcare Professionals of the Primary Care Teams. Likewise, the Junta de Castilla y León ensures that there are appeal campaigns for vaccination in the local clinics needed in each ZBS for those who have not been able to receive the vaccination program against COVID, influenza or both.
In the province of Zamora, to date, 40,614 doses of the new bivalent Covid-19 vaccine have been administered, which means that 26.4% of the general population of Zamora over the age of 60 have already been vaccinated, a much higher figure to the average for Castilla y León (21.4%). Furthermore, the Ministry of Health points out that each Basic Health Zone (ZBS) has a very different number of users and places to be vaccinated, so the speed of vaccination is different in each of them, as is the form of appointment.
According to the national vaccination strategy, the priority groups for joint influenza/covid vaccination are people admitted to nursing homes and other disability centers and the population aged 60 and over, people with conditions at risk and the staff of health and social-health centers due to their greater exposure and possibility of transmission to highly vulnerable people.
In the case of Zamora, following the Joint National Vaccination Strategy, those over 80 have already administered the fourth dose against Covid and the flu in its entirety. Similarly, in rural areas, all patients have been vaccinated in local health centers and clinics except for the ZBS of La Guareña, Aliste, Zamora Norte and Zamora Sur, and Villalpando, where they are vaccinating people over the age of 60 and that should finish in a short period of time. In the rest of the rural Basic Health Zones where vaccination has already been completed, repechages are underway for those people who could not participate at that time.
In the semi-urban areas (Toro and Benavente), vaccination is carried out in the Health Centers, by appointment for urban quotas, for people over the age of 60. He is also completing the vaccination in the missing outpatient clinics in the area. And finally, in urban areas, the doses are administered in the afternoon and to a lesser extent in the morning by appointment to all over-65s, except in the ZBS Virgen de la Concha, who are still in the over-65 age group.
VACCINATION AGAINST INFLUENZA
Health recalls that the 2022-2023 flu vaccination campaign aimed at the general population must request an appointment in advance so that it takes place in a staggered and orderly manner. There are four mechanisms for requesting an appointment: the Salud Castilla y León website, the “Sacyl Conecta” application, by telephone at the administrative units of health centers or with the IVR system (Centro de Cita Previa de Tábara), or by the Healthcare Professionals of the Primary Care Teams.
The Ministry of Health recalls that the groups to be vaccinated against the flu are people over the age of 60, adults and children over the age of six months who suffer from chronic diseases (pulmonary, cardiac, renal, hepatic, oncological, etc. ); people with disabilities and/or cognitive deficits (Down syndrome, dementia,…); chronic institutionalized patients of any age; children and adolescents, aged between six months and eighteen years, subjected to prolonged treatments with acetylsalicylic acid; people with morbid obesity and children aged between six months and two years, with a history of prematurity less than 32 weeks.
